相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses
Yossan-Var Tan et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Bernhard Hemmer et al.
LANCET NEUROLOGY (2015)
Vasoactive Intestinal Peptide-Deficient Mice Exhibit Reduced Pathology in Trinitrobenzene Sulfonic Acid-Induced Colitis
Catalina Abad et al.
NEUROIMMUNOMODULATION (2015)
Using EAE to better understand principles of immune function and autoimmune pathology
Manu Rangachari et al.
JOURNAL OF AUTOIMMUNITY (2013)
Paradoxical Effect of Cortistatin Treatment and Its Deficiency on Experimental Autoimmune Encephalomyelitis
Luciana Souza-Moreira et al.
JOURNAL OF IMMUNOLOGY (2013)
VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model
Angela Storka et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro
Jie Yang et al.
PEPTIDES (2013)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier
Yasunobu Arima et al.
CELL (2012)
An autoimmunity odyssey: how autoreactive T cells infiltrate into the CNS
Naoto Kawakami et al.
IMMUNOLOGICAL REVIEWS (2012)
Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry
Rebecca J. Hermann et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses
Catalina Abad et al.
PLOS ONE (2012)
VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis
Mahesh Yadav et al.
CELLULAR IMMUNOLOGY (2011)
Characterization of Intestinal and Pancreatic Dysfunction in VPAC1-Null Mutant Mouse
Dorit Fabricius et al.
PANCREAS (2011)
Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells
Sheri Tinnell Dorsam et al.
MOLECULAR IMMUNOLOGY (2010)
The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p
Elisa Cocco et al.
PLOS ONE (2010)
Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells
Alessandro Castorina et al.
PEPTIDES (2010)
Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis
Catalina Abad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Localizing Central Nervous System Immune Surveillance: Meningeal Antigen-Presenting Cells Activate T Cells during Experimental Autoimmune Encephalomyelitis
Pia Kivisakk et al.
ANNALS OF NEUROLOGY (2009)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages
Juan Luis Herrera et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
Andrea Reboldi et al.
NATURE IMMUNOLOGY (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
Yossan-Var Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells
Emilie E. Vomhof-DeKrey et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells
Emilie E. Vomhof-DeKrey et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
Postulated Role of Vasoactive Neuropeptide-Related Immunopathology of the Blood Brain Barrier and Virchow-Robin Spaces in the Aetiology of Neurological-Related Conditions
D. R. Staines et al.
MEDIATORS OF INFLAMMATION (2008)
Vasoactive Intestinal Peptide Is Critical for Circadian Regulation of Glucocorticoids
Dawn H. Loh et al.
NEUROENDOCRINOLOGY (2008)
Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis
Elena Gonzalez-Rey et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide
Elena Gonzalez-Rey et al.
GASTROENTEROLOGY (2006)
Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions
Alejo Chorny et al.
REGULATORY PEPTIDES (2006)
Human plasmacytoid dendritic cell function:: Inhibition of IFN-α secretion and modulation of immune phenotype by vasoactive intestinal peptide
Dorit Fabricius et al.
JOURNAL OF IMMUNOLOGY (2006)
Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers
J. M. Hansen et al.
CEPHALALGIA (2006)
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells
E Gonzalez-Rey et al.
BLOOD (2006)
Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis - Down-regulation of inflammatory and autoimmune responses
E Gonzalez-Rey et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Vasoactive intestinal peptide induces CD4+,CD25+T regulatory cells with therapeutic effect in collagen-induced arthritis
E Gonzalez-Rey et al.
ARTHRITIS AND RHEUMATISM (2006)
Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis
A Fernandez-Martin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Autocrine peptide mediators of cerebral endothelial cells and their role in the regulation of blood-brain barrier
B Kis et al.
PEPTIDES (2006)
Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors
V Sharma et al.
JOURNAL OF IMMUNOLOGY (2006)
Vasoactive intestinal peptide generates CD4+ CD25+ regulatory T cells in vivo
M Delgado et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain
KM Joo et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells
M Delgado et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The significance of vasoactive intestinal peptide in immunomodulation
M Delgado et al.
PHARMACOLOGICAL REVIEWS (2004)
VIP: a very important peptide in T helper differentiation
M Delgado
TRENDS IN IMMUNOLOGY (2003)
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease
C Abad et al.
GASTROENTEROLOGY (2003)
Adrenomedullin, an autocrine mediator of blood-brain barrier function
B Kis et al.
HYPERTENSION RESEARCH (2003)
Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide
JK Voice et al.
REGULATORY PEPTIDES (2002)
Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor
P Rameshwar et al.
EXPERIMENTAL HEMATOLOGY (2002)
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia
M Delgado
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
M Delgado et al.
NATURE MEDICINE (2001)
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis
DR Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells
ML Lara-Marquez et al.
JOURNAL OF IMMUNOLOGY (2001)
CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
BT Fife et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
